Cowen And Company, LLC Argenx Se Call Options Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 13, 2021	SELL	$257.11 - $319.92 $1.16 Million - $1.44 Million	-4,500 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$268.3 - $380.31 $134,150 - $190,155	-500 Reduced 10.0%	4,500 $11,000
Q4 2020 Feb 08, 2021	BUY	$248.13 - $308.36 $1.24 Million - $1.54 Million	5,000 New	5,000 $291,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.